Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03G. D’Addario, Daniel Betticher, R. Stahel et al.|Annals of Oncology|2007Cited by 43
Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras-unmutated, locally advanced rectal cancer (LARC): A randomized multicenter phase II trial (SAKK 41/07).Daniel Helbling, Dieter Koeberle, G. Bodoky et al.|Journal of Clinical Oncology|2011Cited by 4